Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
DELPhI software developed for the analysis of EEG recordings in response to magnetic stimulation in relation to clinical data.
Collection of EEG data, recorded at Sagol center for hyperbaric medicine and research in the years of 2017-2019 of patients arriving to be treated at the hyperbaric chamber before,during and after treatments. EEG was recorded of patients during cognitive tests, resting state and during magnetic stimulation as a part of other array of tests performed at the Sagol center. Anonymous EEG data along with MRI scans, PET-CT, SPECT, cognitive tests, Medical history and medications will be transferred to QuantalX Neuroscience LTD.
QuantalX Neuroscience is intending to use the above mentioned data in order to improve DELPhI, an algorithm for the analysis of EEG recordings in response to magnetic stimulation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| healthy |
| ||
| CVA |
| ||
| Hammorhage |
| ||
| TBI |
| ||
| Concussion |
| ||
| Fibromyalgia |
| ||
| ABD |
| ||
| ADHD |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No intervention, this is a retrospective study. | Other | No intervention, this is a retrospective study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Defining Plasticity (the ratio between excitatory to inhibitory brain response) Means and STD in each cohort. | Measure of the mean and STD Plasticity of each cohort. | through study completion, an average of 1 year |
| Defining Connectivity (dispersion of brain signal) Means and STD in each cohort. | Measure of the mean and STD Connectivity of each cohort. | through study completion, an average of 1 year |
| Defining Plasticity (the ratio between excitatory to inhibitory brain response) standard error (SEM) in each cohort. | Measure of the standard error (SEM) of Plasticity of each cohort. | through study completion, an average of 1 year |
| Defining Connectivity (dispersion of brain signal) standard error (SEM) in each cohort. | Measure of the standard error (SEM) of Connectivity of each cohort. | through study completion, an average of 1 year |
| Defining Plasticity (excitation/inhibition brain response) coefficient of variation (CV%) in each cohort. | Measure of the coefficient of variation (CV%) of Plasticity of each cohort. | through study completion, an average of 1 year |
| Defining Connectivity (dispersion of brain signal) coefficient of variation (CV%) in each cohort. | Measure of the coefficient of variation (CV%) of Connectivity of each cohort. | through study completion, an average of 1 year |
| Defining Plasticity (excitation/inhibition brain response) minimum, median, maximum in each cohort. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patient arriving to be treated at the Sagol center for hyperbaric medicine and research at Asaf-Harophe in te years of 2017-2019.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Asaf-Harophe | Rishon LeZiyyon | 70300 | Israel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| MCI |
|
| DEMENTIA |
|
| COGNITIVE IMPAIRMENT |
|
| COGNITIVE DECLINE |
|
| MS |
|
Measure of the minimum, median, maximum of Plasticity of each cohort. |
| through study completion, an average of 1 year |
| Defining Connectivity (dispersion of brain signal) minimum, median, maximum in each cohort. | Measure of the minimum, median, maximum of Connectivity of each cohort. | through study completion, an average of 1 year |
| Defining Plasticity (excitation/inhibition brain response) 95% confidence interval in each cohort. | Measure of the 95% confidence interval of Plasticity of each cohort. | through study completion, an average of 1 year |
| Defining Connectivity (dispersion of brain signal) 95% confidence interval in each cohort. | Measure of the 95% confidence interval of Connectivity of each cohort. | through study completion, an average of 1 year |
| ID | Term |
|---|---|
| D006470 | Hemorrhage |
| D000070642 | Brain Injuries, Traumatic |
| D001924 | Brain Concussion |
| D005356 | Fibromyalgia |
| D001289 | Attention Deficit Disorder with Hyperactivity |
| D003704 | Dementia |
| D019965 | Neurocognitive Disorders |
| D060825 | Cognitive Dysfunction |
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001930 | Brain Injuries |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D006259 | Craniocerebral Trauma |
| D020196 | Trauma, Nervous System |
| D014947 | Wounds and Injuries |
| D016489 | Head Injuries, Closed |
| D014949 | Wounds, Nonpenetrating |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D009468 | Neuromuscular Diseases |
| D019958 | Attention Deficit and Disruptive Behavior Disorders |
| D065886 | Neurodevelopmental Disorders |
| D001523 | Mental Disorders |
| D003072 | Cognition Disorders |
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided